Robeva R, Lagrue J
Vutr Boles. 1989;28(6):43-8.
The problem of accompanying tubular lesions in nephrotic syndrome (NS) is not yet sufficiently clarified. The tubular changes were studied by the urine excretion of sensitive markers: beta 2-microglobulin (beta 2m), alaninaminopeptidase (AAP) and gammaglutamyltranspeptidase (gamma GTP). Beta 2m was determined by ELISA method and AAP and gamma GTP--electrophoretically. 75 patients were examined--37 patients with idiopathic nephrotic syndrome (INS), 27 patients with membranous glomerulonephritis (MGN), 11 patients with membranous-proliferative glomerulonephritis (MPGN). The most sensitive index AAP was elevated in the urine of 97,4% of the patients with nephrotic syndrome, beta 2m was elevated in 64,3% and gamma GTP--in 46,2% of the patients. There is a positive correlation between the excretion of APP and the quantity of proteinuria (r = 0,73, p less than 0,001). The comparison of the results of the patients with and without nephrotic syndrome established that in the patients with idiopathic nephrotic syndrome as well as in the patients with membranous glomerulonephritis the presence of nephrotic syndrome determines the higher excretion of AAP (p less than 0,02). The presence of nephrotic syndrome increases the frequency and the severity of the tubular impairment in glomerulonephritis. The tubular impairment is independent of the histologic type but is in positive correlation with the proteinuria.
肾病综合征(NS)中伴随肾小管病变的问题尚未得到充分阐明。通过敏感标志物的尿排泄情况研究肾小管变化:β2-微球蛋白(β2m)、丙氨酸氨基肽酶(AAP)和γ-谷氨酰转肽酶(γGTP)。采用酶联免疫吸附测定法测定β2m,采用电泳法测定AAP和γGTP。对75例患者进行了检查——37例特发性肾病综合征(INS)患者、27例膜性肾小球肾炎(MGN)患者、11例膜增生性肾小球肾炎(MPGN)患者。肾病综合征患者中,最敏感指标AAP在97.4%的患者尿液中升高,β2m在64.3%的患者中升高,γGTP在46.2%的患者中升高。APP排泄与蛋白尿数量之间存在正相关(r = 0.73,p < 0.001)。对有和无肾病综合征患者的结果进行比较发现,在特发性肾病综合征患者以及膜性肾小球肾炎患者中,肾病综合征的存在决定了AAP的排泄更高(p < 0.02)。肾病综合征的存在增加了肾小球肾炎中肾小管损伤的频率和严重程度。肾小管损伤与组织学类型无关,但与蛋白尿呈正相关。